HallC, McBrideJ, WalshEE, . Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med1983;308:1443–1447.
5.
HallC, McBrideJ, GalaCL, HildrethSW, SchnabelKC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA1985;254:3047–3051.
6.
RodriguezW, KimH, BrandtCD, . Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infectious Dis J1987;6:159–163.
7.
TaberL, KnightV, GilbertBE, . Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics1983;72:613–618.
8.
GroothuisJR, WoodinKA, KatzR, . Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr1990;117:792–798.
9.
SmithDW, FrankelLR, MathersLH, TangATS, AriagnoRL, ProberCG. Aerosolized ribavirin in infants requiring mechanical ventilation for severe lower respiratory tract infection caused by respiratory syncytial virus (abstract). Clinical Research Feb1991;39:A59.
CharneyW, CorkeryKJ, KraemerR, WugofskiL.Engineering and administrative controls to contain aerosolized ribavirin: Results of simulation and application to one patient. Respir Care1990;35:1042–1048.
12.
California Department of Health. Health care workers exposure to ribavirin aerosol. Field Investigation FI-86-009. Feb1, 1988.
13.
Massachusetts Department of Labor and Industries, Div of Occupational Hygiene. Ribavirin alert. DOH# 1588. July1989.
